Figure S6 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice
Gabrilo J., Vande Velde S., Henin C., Denanglaire S., Azouz A., Boon L., Van den Eynde BJ., Moser M., Goriely S., Leo O.
Enhanced responsiveness to immunotherapy is associated with increased levels of terminally exhausted CD8 T cell signatures